Mayank Mamtani

Stock Analyst at B. Riley Securities

(4.59)
# 252
Out of 5,042 analysts
136
Total ratings
49.58%
Success rate
41.68%
Average return

Stocks Rated by Mayank Mamtani

Zymeworks
Oct 10, 2025
Initiates: Buy
Price Target: $30
Current: $17.74
Upside: +69.11%
Harrow
Oct 1, 2025
Reiterates: Buy
Price Target: $70$74
Current: $38.52
Upside: +92.11%
Madrigal Pharmaceuticals
Sep 29, 2025
Maintains: Buy
Price Target: $460$560
Current: $421.50
Upside: +32.86%
Nektar Therapeutics
Sep 23, 2025
Maintains: Buy
Price Target: $85$105
Current: $60.10
Upside: +74.71%
Cytokinetics
Sep 22, 2025
Maintains: Buy
Price Target: $74$80
Current: $57.83
Upside: +38.34%
TG Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $53$55
Current: $33.34
Upside: +64.99%
Theravance Biopharma
Sep 12, 2025
Initiates: Buy
Price Target: $28
Current: $14.25
Upside: +96.49%
Actuate Therapeutics
Aug 26, 2025
Initiates: Buy
Price Target: $20
Current: $7.20
Upside: +177.78%
Altimmune
Aug 13, 2025
Maintains: Buy
Price Target: $20$18
Current: $3.95
Upside: +355.70%
MediciNova
Jun 16, 2025
Maintains: Buy
Price Target: $6$5
Current: $1.23
Upside: +308.16%
Maintains: Neutral
Price Target: $5$3
Current: $1.84
Upside: +63.04%
Maintains: Buy
Price Target: $2.5$2
Current: $0.36
Upside: +454.02%
Reiterates: Buy
Price Target: $11$20
Current: $10.51
Upside: +90.29%
Maintains: Buy
Price Target: $4$3
Current: $1.70
Upside: +76.47%
Reiterates: Buy
Price Target: $38$35
Current: $15.96
Upside: +119.30%
Reiterates: Buy
Price Target: $51$38
Current: $38.00
Upside: -
Reiterates: Buy
Price Target: $109$96
Current: $34.42
Upside: +178.91%
Upgrades: Buy
Price Target: $1$1.5
Current: $1.73
Upside: -13.29%
Reiterates: Buy
Price Target: $23$26
Current: $8.52
Upside: +205.16%
Initiates: Buy
Price Target: $33
Current: $24.15
Upside: +36.65%
Initiates: Buy
Price Target: $140
Current: $16.31
Upside: +758.37%
Maintains: Buy
Price Target: $210$90
Current: $3.80
Upside: +2,268.42%
Reiterates: Buy
Price Target: $160
Current: $4.14
Upside: +3,764.73%
Downgrades: Neutral
Price Target: $11$5
Current: $1.98
Upside: +152.53%
Maintains: Buy
Price Target: $58$44
Current: $3.78
Upside: +1,064.02%
Maintains: Buy
Price Target: $120$90
Current: $2.51
Upside: +3,485.66%
Downgrades: Neutral
Price Target: $14$7
Current: $1.90
Upside: +268.42%
Maintains: Buy
Price Target: $9,750$4,500
Current: $1.49
Upside: +301,913.42%
Maintains: Buy
Price Target: $5,000$2,700
Current: $1.88
Upside: +143,517.02%
Downgrades: Neutral
Price Target: $138$77
Current: $11.22
Upside: +586.27%
Downgrades: Neutral
Price Target: $1,980$1,440
Current: $1.38
Upside: +104,247.83%
Maintains: Buy
Price Target: $8$4
Current: $5.23
Upside: -23.52%
Maintains: Buy
Price Target: $47$39
Current: $94.65
Upside: -58.80%
Maintains: Buy
Price Target: $43$34
Current: $4.29
Upside: +693.47%